UnitedHealth Group Inc (NYSE:UNH) – Analysts at Jefferies Group raised their Q4 2018 earnings per share (EPS) estimates for shares of UnitedHealth Group in a research note issued to investors on Friday. Jefferies Group analyst D. Windley now anticipates that the healthcare conglomerate will post earnings of $3.11 per share for the quarter, up from their prior forecast of $2.80. Jefferies Group has a “Buy” rating and a $248.00 price target on the stock.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same period in the prior year, the company posted $2.17 EPS. The company’s revenue was up 8.7% compared to the same quarter last year.

Several other research firms have also weighed in on UNH. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Cantor Fitzgerald reiterated a “buy” rating and issued a $225.00 price objective on shares of UnitedHealth Group in a research note on Monday, November 27th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Piper Jaffray Companies upped their price objective on UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a research note on Tuesday, October 17th. Finally, Credit Suisse Group started coverage on UnitedHealth Group in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price objective on the stock. Three analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $229.54.

UnitedHealth Group (UNH) traded up $3.25 during mid-day trading on Monday, hitting $228.64. The stock had a trading volume of 3,943,700 shares, compared to its average volume of 2,822,722. UnitedHealth Group has a 52 week low of $156.09 and a 52 week high of $231.77. The company has a market cap of $221,060.00, a price-to-earnings ratio of 25.98, a P/E/G ratio of 1.54 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

Large investors have recently bought and sold shares of the business. Blue Chip Partners Inc. acquired a new position in UnitedHealth Group during the 2nd quarter worth $110,000. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its stake in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $121,000. Finally, Acrospire Investment Management LLC lifted its stake in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the period. 86.09% of the stock is currently owned by hedge funds and other institutional investors.

In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 34,630 shares of company stock worth $7,669,416. Company insiders own 0.89% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Q4 2018 EPS Estimates for UnitedHealth Group Inc Boosted by Analyst (UNH)” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/15/q4-2018-eps-estimates-for-unitedhealth-group-inc-boosted-by-analyst-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.